| Literature DB >> 33649568 |
Kenji Sugata1, Yukiko Matsunaga1, Yuki Yamashita1, Munehide Nakatsugawa1, Tingxi Guo1, Levon Halabelian2, Yota Ohashi1,3, Kayoko Saso1, Muhammed A Rahman1, Mark Anczurowski1,3, Chung-Hsi Wang1,3, Kenji Murata1, Hiroshi Saijo1, Yuki Kagoya1, Dalam Ly1, Brian D Burt1, Marcus O Butler1,3,4, Tak W Mak1,3, Naoto Hirano5,6.
Abstract
Peptide-major histocompatibility complex (pMHC) multimers enable the detection of antigen-specific T cells in studies ranging from vaccine efficacy to cancer immunotherapy. However, this technology is unreliable when applied to pMHC class II for the detection of CD4+ T cells. Here, using a combination of molecular biological and immunological techniques, we cloned sequences encoding human leukocyte antigen (HLA)-DP, HLA-DQ and HLA-DR molecules with enhanced CD4 binding affinity (with a Kd of 8.9 ± 1.1 µM between CD4 and affinity-matured HLA-DP4) and produced affinity-matured class II dimers that stain antigen-specific T cells better than conventional multimers in both in vitro and ex vivo analyses. Using a comprehensive library of dimers for HLA-DP4, which is the most frequent HLA allele in many ancestry groups, we mapped 103 HLA-DP4-restricted epitopes derived from diverse tumor-associated antigens and cloned the cognate T-cell antigen receptor (TCR) genes from in vitro-stimulated CD4+ T cells. The availability of affinity-matured class II dimers across HLA-DP, HLA-DQ and HLA-DR alleles will aid in the investigation of human CD4+ T-cell responses.Entities:
Year: 2021 PMID: 33649568 DOI: 10.1038/s41587-021-00836-4
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908